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Survival of Resting Mature B Lymphocytes
Depends on BCR Signaling via the Ig/ Heterodimer
connected to downstream protein kinases and adaptor
molecules (Kurosaki, 2002; Gauld et al., 2002). Gene
targeting experiments have shown that the cytoplasmic
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and Department of Pathology tails of these molecules, and in particular their ITAM
motifs are crucial for B cell development (Kraus et al.,Harvard Medical School
200 Longwood Avenue 2001; Reichlin et al., 2001; Torres et al., 1996), and that
the signals transduced through the Ig/Ig heterodimerBoston, Massachusetts 02115
2 Institute for Genetics are involved in both positive and negative selection of
the developing B cells (Kraus et al., 1999; Torres andUniversity of Cologne
Weyertal 121 Hafen, 1999).
The notion of a checkpoint in B cell developmentD-50931 Cologne
Germany marked by BCR expression was based on gene targeting
experiments in which components of the BCR were inac-3 New York University
Department of Biology tivated by germline mutations (Rajewsky, 1996) or Ig
was downregulated at the immature B cell stage (Meffre1009 Main Building
100 Washington Square East and Nussenzweig, 2002). However, a subsequent exper-
iment resulting in the ablation of the BCR in mature BNew York, New York 10003
cells suggested that rather than marking a develop-
mental checkpoint, the dependence of B cell mainte-
nance on BCR expression is a characteristic feature ofSummary
B cell physiology from the stage of immature B cell
generation in fetal liver or bone marrow (BM) to that ofWe previously showed that type I interferon-induced,
Cre-mediated ablation of surface BCR expression in the mature, long-lived B cell populating the peripheral
B cell compartment (Lam et al., 1997).mature B cells through Ig-heavy chain deletion results
in apoptosis of these cells. This led to the hypothesis Although other work indirectly supports this view
(Fuentes-Panana et al. 2004), the above interpretationthat survival signals from the BCR are vital for mature
B cells. Here, we test two critical assumptions of this of the Lam et al. experiment remained speculative for
two reasons. While it was evident that BCR ablation onmodel. First, we demonstrate loss of mature B cells
upon induced mutation of a signaling module of the mature B cells led to apoptotic cell death, it remained
to be established that this was due to the loss of BCRBCR, not precluding BCR surface expression. Second,
we show that the cells are also lost upon BCR inactiva- signaling. Clearly, other interpretations are possible,
such as the BCR serving as a scaffold for another signal-tion in the absence of an exogenous inducer like inter-
feron, excluding that cell death depends on previous ing structure or, in a more trivial way, that loss of BCR
surface expression leads to cell death because of im-cellular activation by the latter. Kinetic data demon-
strate that BCR-less mature B cells have a severely proper processing of its components in the endoplasmic
reticulum (Harding et al., 2002; Allison et al., 1991). An-reduced lifespan, with a half-life of 3–6 days. Together
these results establish that BCR signaling is required other problem with the interpretation of the Lam et al.
experiment is that type I interferon (IFN) was used forto keep resting mature B cells alive in vivo.
the induction of Cre-mediated BCR ablation. As IFN is
known to be a potent, albeit transient B cell activatorIntroduction
(Braun et al., 2002), the loss of B cells upon IFN-induced
BCR ablation could rely on previous activation of theThe B cell antigen receptor (BCR) consists of membrane
bound immunoglobulin (Ig) and the signal-transducing cells, akin to activation-induced cell death in T cells
(Krueger et al., 2003), rather than truly reflecting apopto-Ig/Ig heterodimer (Kurosaki, 2002; Reth and Wie-
nands, 1997). Its expression on the B cell surface marks sis of resting, mature cells.
In order to clarify these matters, we have establisheda checkpoint in B cell development, in that cells express-
ing BCRs of “innocent” specificities survive and further additional systems of conditional BCR mutagenesis,
allowing us to demonstrate that in the absence of appro-mature, whereas expression of autorective BCRs leads
to their substitution by innocent ones or cellular apopto- priate BCR signaling mature, resting B cells are lost from
the peripheral immune system of the mouse with a half-sis (Nemazee, 2000). There is evidence that these cellu-
lar decisions depend upon BCR signaling through the life of 3–6 days.
Ig/Ig heterodimer. The cytoplasmic tails of these pro-
teins contain tyrosine residues, most prominently tyro- Results
sines assembled into the so-called immunoreceptor ty-
rosine-based activation motif (ITAM; Reth, 1989), which Experimental Design
are phosphorylated upon BCR triggering. Igand Igare Our experiments aimed at the targeted inactivation of
BCR components in mature B cells in such a way, that
complete BCR deletion could be compared with specific*Correspondence: rajewsky@cbr.med.harvard.edu
4 These authors contributed equally to this work. interference with BCR signaling in an inducible system
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Figure 1. Conditional Alleles and cre-Transgenics
(A) Loci before (floxed) and after Cre-mediated recombination (mutated). Coding regions are displayed as boxes (L, leader; Ex, extracellular;
Tm, transmembrane; and Cyt, cytoplasmic domain) a white box represents the 3 UTR and boxes with a triangle indicate loxP sites.
(B) cre transgenes mediating Cre expression in a stage specific (CD21-cre) or inducible manner (Mx-cre).
as well as a developmentally controlled fashion in the transgenic strains showed that the CD21-cre3A strain
mediated efficient Cre recombination in mature, but notabsence of an exogenous inducer.
For these purposes two loxP-flanked alleles of the Ig immature, transitional B cells (Supplemental Figure S2
available on Cell website). This strain was chosen for theencoding mb-1 gene were established, one allowing
complete Ig inactivation upon Cre-mediated recombi- experiments described in this paper and is designated
CD21-cre hereafter. B cell development was unaffectednation (IgTmf), the other a mutation of the Ig cyto-
plasmic tail (IgC1f ). Previous work has shown that in the by the CD21-cre transgene in that B cell numbers and
subset distribution were indistinguishable from controlsabsence of Ig both surface expression of the BCR and
B cell development are abolished (Pelanda et al., 2002; (data not shown).
Minegishi et al., 1999; Wang et al., 2002), whereas similar
mutations of the Ig tail allow BCR expression, but inter- Both Induced Deletion and Cytoplasmic Tail
Mutation of Ig Lead to the Loss of Mature B Cellsfere dramatically with BCR signaling and lead to an al-
most complete block of B cell development (Flaswinkel A first set of experiments was carried out in analogy to
those of Lam et al. (1997), except that the conditionaland Reth, 1994; Torres et al., 1996). To achieve inducer-
independent initiation of Cre expression in mature B alleles of Ig were used instead of inactivating the IgH
chain (Figures 2A and 3A). The system of inducible Igcells, we established cre-transgenic strains (CD21-cre)
in which the cre gene is inserted into the CD21/35 locus deletion offers an advantage over that of inducible IgH
ablation in that it avoids a possible alteration of B cellon a transgenic bacterial artificial chromosome. The
CD21/CD35 proteins are expressed in B cell develop- development by restricting the BCR repertoire to a sin-
gle IgH specificity. More importantly, however, we couldment at the time when immature, transitional B cells
differentiate into mature long-lived peripheral B cells compare the effect of BCR ablation by induced Ig inac-
tivation to that of interference with BCR signaling(Takahashi et al., 1997).
The two conditional Ig alleles and the previously de- through Ig tail mutation (using the IgC1f allele). Through-
out the work, the experimental mice carried a conditionalscribed B1-8f allele (which allows conditional deletion
of the Ig heavy [IgH] chain) are schematically depicted Ig allele together with an Ig null allele (IgTm, gener-
ated from IgTmf as described in the Supplemental Mate-in Figure 1A. Figure 1B illustrates the newly established
CD21-cre together with the IFN-sensitive Mx-cre trans- rial, Supplemental Figure S3 available on Cell website),
in order to allow a direct determination of the fractiongene (Kuhn et al., 1995). A detailed description of the
Ig conditional alleles and of the CD21-cre strains is of cells expressing mutant, but not floxed, Ig alleles
by Southern analysis. Expression of a single wild-typegiven in the Supplemental Material (Supplemental Fig-
ures S1 and S2 available at http://www.cell.com/cgi/ Ig allele is sufficient to mediate normal B cell develop-
ment (data not shown).content/full/117/6/787/DC1). The Ig tail mutation elimi-
nates the membrane-proximal part of the Ig cyto- Two weeks after two p(I)/p(C) injections, an essentially
complete block of B cell development in the BM wasplasmic tail and disrupts the ITAM motif. To ensure that
the conditional Ig alleles had the desired functional observed (Figure 2B), corresponding to an overall dele-
tion of the IgTmf allele of 84% (Figure 2D). In the spleen,properties, we transmitted their deleted versions into
the mouse germ line and showed that they severely this led to an almost complete absence of immature
(CD19CD23CD21) B cells, which represent up toimpeded B cell development, consistent with earlier
work (Pelanda et al., 2002; Torres et al., 1996). We also 15% of all splenic B cells (Figure 2B, and Supplemental
Table S2 available on Cell website). Beyond this, aboutshowed that the loxP-flanked alleles allowed normal B
cell development (Supplemental Figure S3 available on two thirds of the B cells were lost over two weeks after
a single or two subsequent p(I)p(C) injections (FigureCell website and data not shown). Analysis of the cre-
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Figure 2. Induced Ig Deletion Causes Rapid Loss of Peripheral B Cells
(A) Scheme showing induced Ig ablation upon p(I)/p(C) injections.
(B) Representative FACS analysis of BM, left, and splenic lymphocytes, right, at day 14 after the first of two inductions. Induced Ig ablation
led to the disappearance of the CD43B220lo fraction of pre- and immature B cells. Numbers represent percentages of cells within the
lymphocyte gate or of cells within the CD19 B cell fraction (as indicated).
(C) Loss of splenic (CD19CD21) B cells upon Cre-mediated deletion of Ig over time. Each circle represents a single IgTmf/Tm  Mx-cre
mouse. B cell numbers (i) at days 12 and 14 after two p(I)/p(C) injections, (ii) at different time points after a single p(I)/p(C) injection.
(D) Southern blot analysis to determine the ratio of floxed (Tmf) versus deleted (Tm) Ig alleles in total BM, splenic B (CD19, MACS-purified)
and non-B (CD19) cell fractions of IgTmf/Tm  Mx-cre mice. Mice were injected twice with p(I)/p(C) and analyzed 14 days after the first
injection. The splenic non B-cell fraction from IgTmf/TmMx-cre mice indicates deletion efficiency in peripheral cells. Band intensities were
quantified and are displayed as percentages of the floxed and deleted Ig alleles. Note that IgTmf/Tm mice carry only one functional Ig allele
(Tmf). Thus, prior to p(I)/p(C) treatment and also in Mx-cre negative controls, 50% of the Ig band-intensity/locus is represented by Tm. The
fraction of cells with the rearranged IgTm/Tm genotype is indicated at the bottom.
(E) Transient appearance of Ig cells upon induced deletion of Ig. Representative FACS analysis of splenic lymphocytes from IgTmf/TmMx-
cre mice four days after a single p(I)/p(C) injection. For comparison cells from an untreated littermate are shown. Numbers represent either
the B cell fraction within the lymphocyte gate (upper image) or of IgMIgD cells in the CD19 B cell fraction (lower image).
(F) Ig cells appear following the induced Ig deletion and then disappear with time. The mutation was induced 1 at day 0. PBLs from
groups of six to eight IgTmf/TmMx-cre mice were analyzed for each time point.
(G) Comparison of surface expression levels on Ig and Ig B cells from the spleen and inguinal lymph node (LN) of IgTmf/TmMx-cre mice
four days after a single induction (upper images). Expression levels on B cells from IgTmf/Tm controls are shown in the lower images. The
shaded graph in the IgD histogram represents T lymphocytes.
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Figure 3. Induced Deficiency in Ig Signaling
(A) Scheme showing the induced Ig tail mutation upon p(I)/p(C) injections.
(B) Loss of mature B cells and block of B cell generation in the BM following induced Ig mutation. The population of MZ B cells is stable in
size. Representative FACS analysis of splenic and BM lymphocytes at day 14 after the first of three inductions. Numbers indicate the
percentages of cells within the lymphocyte gate (upper images) or within the CD19 B cell compartment.
(C) Splenic B cell numbers were determined in IgC1f/C1f (black circle) and IgC1f/C1fMx-cre (red circle) mice at day 14 after three p(I)/p(C) injections.
Each circle represents a single mouse.
(D) Southern blot analysis of genomic DNA prepared from BM of IgC1f/Tm  Mx-cre mice at day 14 after three inductions. DNA was digested
with BamHI and hybridized with the 5 external probe (Supplemental Figure S1A available on Cell website). The presence of some IgC1 alleles
in the non-induced IgC1f/TmMx-cre sample indicates background Cre expression due to the Mx-cre transgene.
(E) Similar recombination efficiency of the Ig locus in B and non-B splenocytes four days after a single induction. Splenic cells from IgC1f/Tm 
Mx-cre mice were separated by MACS into B (CD19) and non-B (CD19) cell fractions. Genomic DNA from these fractions was digested
with BamHI and used in a Southern analysis with a probe specific for exon II of the mb-1 gene (Supplemental Figure S1A available on Cell
website). Note that this probe does not detect the IgTm allele.
(F) Loss of mutant splenic B cells in IgC1f/TmMx-cre mice. Southern blot analysis of genomic DNA prepared from FACS-sorted splenic B and
non-B cell fractions (CD19) at day 13 after a single induction. CD19 B cells were further subdivided into CD21brightCD23lo marginal zone (MZ)
and CD21CD23 follicular (FO) B cells. DNA was digested with BamHI and hybridized with the 5 external probe (Supplemental Figure S1A
available on Cell website). Note that the fragment sizes for the IgC1/IgTm alleles are identical. Thus, prior to p(I)/p(C) treatment and also in
Mx-cre negative controls, 50% of the Ig band-intensity is represented by the IgTm allele.
2C). This cell loss affected mature follicular B cells, contrast to the non-B cells in the spleen (Figure 2D).
The efficient deletion in these latter cells (74%; Figurewhereas B cells of the marginal zone (MZ) subset were
only slightly reduced (Supplemental Table S2 available 2D) together with the fact that in this system the deletion
efficiency in splenic B and non-B cells is similar (seeon Cell website). The remaining cells had largely es-
caped Ig deletion, as shown by Southern blotting, in Figure 3F; Kuhn et al., 1995) indicates that B cells with
Resting B Cell Survival Depends on BCR Signaling
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an inactivated Ig allele are lost within a period of one Interestingly, two to three weeks after either induced
to two weeks. Given that over 60% of splenic B cells Ig tail mutation or Ig deficiency splenic MZ B cell
are mature, follicular cells (Supplemental Table S2 avail- numbers (CD23loCD21bright) were not affected (Supple-
able on Cell website), which are very long-lived in the mental Table S2 available on Cell website), and within
absence of B cell influx from the bone marrow (Hao and the remaining B cells the fraction of MZ B cells was
Rajewsky, 2001; Grabstein et al., 1993), such cells must increased compared to controls (Figures 2B and 3B).
be included in those that are lost upon Ig deletion. B To test whether MZ B cells differ from follicular B cells
cell loss was also apparent in blood, lymph nodes, liver, in their dependence on BCR signaling, spleen cells from
and lung (data not shown). Combined B cell numbers IgC1f/TmMx-cre mice were separated by FACS into MZ-,
(identified as B220 cells) in liver and lung were less than follicular-, and non-B cells two weeks after induced mu-
1  106 and reduced compared to non-cre transgenic tagenesis. As in the case of follicular B cells, MZ B cells
controls. This argues that the BCR-deficient cells do not of the IgC1/Tm genotype were hardly detectable, the
just home to unusual locations, but rather disappear cells carrying the functional IgC1f allele instead (Figure
from the body. 3F). Assuming that the efficiency of mutagenesis in the
Directly demonstrating BCR ablation, B cells with various B cell subsets is similar, this implies that also
downregulated BCR expression (designated Ig cells) MZ B cells depend on an Ig/mediated survival signal.
appeared early on in the experiment in spleen, lymph Following loss of the mutant cells, the MZ B cell com-
nodes, blood, and BM (Figure 2E and data not shown). partment is presumably replenished from MZ B cells
On day four after a single Cre induction the Ig fraction that have escaped mutation, in accord with previous
comprised about one quarter (24 5%; n	 5) of splenic work (Hao and Rajewsky, 2001).
B cells. Downregulation affected BCRs of both the IgM
and the IgD class (Figure 2E). At later time points, such BCR Mutation in Mature B Cells in the Absence
cells could no longer be identified in the periphery. The of an Endogenous Inducer
transient appearance of Ig B cells in the peripheral Mutagenesis in mature B cells in the absence of an
blood after Cre induction is depicted in Figure 2F. In exogenous inducer was achieved using the newly devel-
accordance with the data of Lam et al. (1997), Ig cells oped CD21-cre transgene (Figure 1B and Supplemental
exhibited slight upregulation of CD19 and downregula- Figure S2 available on Cell website). We analyzed this
tion of MHC class II and CD45/B220. In addition, the transgene in combination with the two conditional Ig
complement receptors CD21/CD35 were downregu- alleles and the B1-8f allele.
lated on Ig cells. We could not detect, however, upreg- In accordance with the pattern of CD21-controlled
ulation of Fas and increased annexin V binding as had Cre expression, the compartments of pro-, pre-, and
been reported by Lam et al. (1997; Figure 2G). Taken immature-B cells in the BM of B1-8f/JHT-CD21-cre,together, these results demonstrate that as in the case IgC1f/TmCD21-cre and IgTmf/TmCD21-cre mice were un-
of IgH inactivation (Lam et al., 1997), mature B cells are affected (Figure 4A, Table 1, and data not shown). Simi-
lost upon BCR ablation through Ig deletion. larly, the numbers of splenic transitional-T1 B cells
Are mature B cells also lost upon induced Ig tail
(CD19CD21CD23) were comparable to those in non-
mutation? Comparison of peripheral B cell populations
cre-transgenic littermate controls (data not shown).
shortly after induced mutagenesis with control cells
However, there was a dramatic loss of mature B cells
showed that sIg levels on the mutant cells were largely
in all three mutant strains. Thus, the mature B cells inretained, with a maximal reduction of mean fluorescence
the BM (Fraction F, B220brightIgM) were reduced by morevalues from 30 to 50% (data not shown). Thus, the mu-
than 50% (Figure 4A, Table 1), and in the spleen MZ andtant B cells cannot be identified in a mixed population
follicular B cells were reduced to about one third ofby flow cytometry due to the wide range of sIg levels
control values. B cell numbers were also strongly re-on B cells. However, similar to induced Ig ablation,
duced in the inguinal lymph nodes (Figure 4A, Table 1).p(I)/p(C)-induced Ig tail mutation resulted in the loss
The reduction of the size of the mature B cell compart-of the majority of the B cells in spleen and lymph nodes
ment was stable over time (data not shown).over a comparable time period (Figures 3B and 3C; Sup-
Strikingly, about one third of B cells in the spleen andplemental Table S2 available on Cell website). Southern
up to one half in the inguinal lymph nodes ofanalysis indicated efficient Ig tail mutation in splenic
IgTmf/TmCD21-cre mice expressed low to undetectableB cells at day four after induction (Figure 3E). At later
levels of surface IgM/IgD (designated Ig as above; Ta-time points, mutant B cells were hardly detectable (Fig-
ble 1) when compared to non-B and IgG1 B cells byure 3F, and data not shown), indicating that as in the
flow cytometry. This corresponds to an at least 30- andcase of Ig deletion, the B cells persisting in the spleen
100-fold reduction of the levels of sIgM and sIgD, re-had escaped Cre-mediated recombination. This was ac-
spectively (data not shown). While Ig cells were notcompanied by efficient mutagenesis in the BM (Figure
detectable in the IgC1f/TmCD21-cre strain, they were3D), resulting in a block of B cell development and a
also present in B1-8f/JHT-CD21-cre mice, although indramatic reduction of immature B cells in the spleen
lower numbers. The Ig cells in both strains expressed(Figure 3B). As argued above, this implies that the loss
higher levels of CD19, but less MHC II, CD21/35, andof cells upon induced Ig tail mutation must involve
B220 on the surface than Ig cells (Figure 4B; and datamature splenic B cells.
not shown), resembling the Ig cells that appeared inThus, interference with BCR signaling through IFN-
IgTmf/TmMx-cre mice shortly after induced mutagenesis.induced Ig tail mutation leads to the loss of mature B
From these results, we envisaged a scenario of B cellcells, similar to BCR ablation through induced IgH or
Ig inactivation. development in IgTmf/TmCD21-cre and B1-8f/JHT-CD21-
Cell
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cre mice as illustrated in Figure 6A; B cells emigrate as C1qRp (recognized by the monoclonal antibody AA4.1)
as a critical marker. Also in this analysis most splenicimmature Ig cells into the periphery, where they mature
and eventually undergo CD21-controlled Ig or heavy B cells in IgTmf/TmCD21-cre mice were transitional cells
(AA4.1B220). Subdivision of AA4.1B220 transitionalchain ablation. Upon loss of surface Ig expression the
cells enter the pool of Ig cells, but are rapidly lost, B cells into T1, T2, and T3 fractions according to the
expression levels of CD23 and IgM (Figure 4C) demon-causing the overall reduction of the size of the mature
B cell compartment. This scenario would also hold for strated that only a fraction of the more mature transi-
tional cells had lost surface Ig. Ig cells were not presentthe B cells in IgC1f/TmCD21-cre mice, except that here
the mutant cells retain BCR expression and can thus at the T1 (CD23) stage, and the fraction of the T2
(CD23IgMhiAA4.1B220) population was of normalnot be easily discriminated by flow cytometry. B cell
numbers were reduced in these animals to the same size. Only the T3 (CD23IgMAA4.1B220) population
was reduced, indicative of Cre-activity in some B cellsextent as in the case of induced Ig ablation, and the
fraction of splenic B cells having undergone Ig tail at this later developmental stage. Clearly, however, most
Ig cells were mature, AA4.1B220 B cells. Some ofmutation was around 30% (Figure 4E), closely corre-
sponding to the fraction of splenic Ig B cells of animals these cells were CD23 and thus likely originate from MZ
B cells (Figure 4C). Gating on the Ig cells in individualin which Ig is ablated through the CD21-cre transgene.
Because of the enhanced response of immature BM B animals, we found that two thirds or more of them were
AA4.1 (data not shown). We conclude that most Ig Bcells to certain BCR-mediated signals upon Ig trunca-
tion (Kraus et al., 1999; Torres and Hafen, 1999), we cells in the mutant animals are derived from mature Ig
B cells.analyzed the splenic B cells in IgC1f/TmCD21-cre mice
for signs of activation, namely upregulation of MHCII,
CD69, and CD86. No such upregulation was seen, but BCR-Deficient Mature B Cells Have
a Half-Life of 3–6 Daysinstead a fraction of the cells exhibited MHCII and B220
downregulation (and upregulation of CD19), as seen on The conversion rate of Ig into Ig B cells and the half-
lives of the latter cells in IgTmf/Tm- and B1-8f/JHT CD21-mature B cells having lost BCR expression (data not
shown). cre transgenic mice were measured by BrdU incorpora-
tion. Mice were fed BrdU in the drinking water for twoA critical assumption in the scenario depicted in Fig-
ure 6A is that the Ig cells in the mutant animals (which weeks, followed by a chase period of several weeks. A
typical experiment in IgTmf/TmCD21-cre mice andhave undergone Cre-mediated recombination in con-
trast to their Ig counterparts; Figure 4D) indeed derive IgTmf/Tm control littermates is depicted in Figures 5A
and 5B. As expected, there was little BrdU incorporationfrom mature B cells. This became apparent from the
surface phenotype of these cells. Thus, the Ig cells in into the (mostly long-lived) circulating B cells in control
animals (Figure 5B; Forster and Rajewsky, 1993). Bythe spleen of IgTmf/TmCD21-cre mice were CD43 and
expressed CD21/35, a characteristic marker of B cells contrast, in IgTmf/TmCD21-cre mice, the bulk of the Ig
B cells were rapidly labeled. BrdU incorporation into thebeyond the transitional T1 stage (Figure 4B). In addition,
while most Ig cells in IgTmf/TmCD21-cre mice were Ig cells was delayed by comparison, and the labeled
cells were rapidly and sequentially lost from both popu-HSAbright, indicating that they were mainly transitional
cells, Ig cells expressed low levels of HSA (Figure 4B). lations. These observations are in agreement with the
model in Figure 6A, which predicts that the label isSimilar results were obtained when the splenic B cells
of the mutant animals were classified into transitional chased from Ig cells into the Ig population and lost
from the latter as the cells disappear from the system.and mature cells according to Allman et al. (2001), using
Figure 4. Inducer Independent Mutation in Resting Mature B Cells
(A) Reduced mature B cell pool in mice with CD21-cre mediated ablation or altered signaling capacity of the B cell receptor. Flow cytometric
analysis of BM, spleen and iLN lymphocytes from mice carrying a floxed IgC1f, IgTmf, or B1-8f allele in combination with the CD21-cre
transgene. Bone marrow cells were stained with anti-B220 and anti-IgM antibodies and the pro/pre-B (B220loIgM), immature (B220loIgM)
and mature (B220hiIgM) B cell subpopulations were gated accordingly. Percentage of total lymphocytes is indicated. Splenocytes were
stained with anti-CD5, anti-CD19, anti-IgD, and anti-IgM antibodies. Numbers refer to the percentage of cells in the lymphocyte gate, or of
Ig cells within the total B cell population. iLN cells were stained with anti-CD19, anti-IgM, and anti-IgD antibodies to determine the percentages
of Ig and Ig B cells (CD19).
(B) Most B cells acquire the CD21-cre mediated Ig mutation at the mature stage. FACS analysis of splenic Ig and Ig lymphocytes in
IgTmf/TmCD21-cre mice and IgTmf/Tm controls. B cells were stained with CD19, Fab fragment goat anti-mouse IgG (HL), CD21, and CD23.
The majority of Ig cells are CD23CD21 (middle image), but express lower levels of CD21. The histograms in the lower image show surface
levels of HSA and MHC class II. Most Ig B cells from IgTmf/TmCD21-cre mice are HSAbright indicative of a transitional stage, while Ig cells
are HSAlo.
(C) Splenic B cells were stained for B220, IgM, CD23, and AA4.1 C1qRp to characterize transitional and mature B cell fractions in IgTmf/
TmCD21-cre mice. The histogram on the right compares AA4.1/C1qRp levels in the transitional (AA4.1) B cell compartment from IgTmf/TmCD21-
cre mice. AA4.1/C1qRp levels drop during development from T1 to T3. Note that Ig B cells have the lowest AA4.1/C1qRp expression levels.
(D) Ig B cells in IgTmf/TmCD21-cre mice have acquired the IgTm and lost the floxed Igtmf allele. Shown is a Southern analysis of BamHI
digested genomic DNA from FACS sorted IgMloIgDlo (Ig) and IgMIgD (Ig) splenic B cells. The C1C2-probe (Supplemental Figure S1 available
on Cell website) detects both the IgTmf and the IgTm allele.
(E) Determination of the fraction of splenic B cells in IgC1f/TmCD21-cre mice that acquired the IgC1 allele. Genomic DNA from spleen cells
separated by MACS into B (CD19) and non-B (CD19) cells was digested with BamHI and used in combination with the exonII-probe
(Supplemental Figure S1 available on Cell website) in a Southern analysis. Data are representative of four experiments.
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Figure 5. B Cell Lifespans in IgTmf/TmCD21-cre Mice
BrdU incorporation in peripheral blood B lymphocytes of IgTmf/TmCD21-cre mice (A) and IgTmf/Tm controls (B) during a two weeks pulse and
a subsequent chase. Shown is the percentage of BrdU cells within the Ig () and Ig () fraction. Each symbol represents a single mouse.
Green symbols represent splenic B cells. Curves representing the loss of BrdU cells (Ig black; Ig red) are based on the indicated calculated
half-lives as outlined in Experimental Procedures.
(C) Block of B cell generation in the BM by anti-IL7R Mab treatment causes an increase of the Ig fraction within the peripheral B cell pool.
B cells from the peripheral blood were analyzed by FACS at day 4 and 11.
(D) Ig () and Ig () splenic B cell numbers of IgTmf/TmCD21-cre mice upon block of B cell generation by anti-IL7R Mab treatment. Symbols
represent individual mice. Shown are calculated decay curves for the Ig (black) and Ig (red) B cells. For further explanation see text.
At two time points, BrdU incorporation into splenic B range of Ig:Ig ratios in the calculations, half-lives for
the Ig cells ranging from 3–6 days were obtained forcells was also determined and was similar to that ob-
tained for the cells in peripheral blood (Figure 5A). Col- both compound mutants (Supplemental Table S3 avail-
able on Cell website).lectively, these results are suggestive of a rapid conver-
sion of newly arising Ig into Ig cells, which are then The model in Figure 6A combined with the half-lives
of Ig and Ig cells from the BrdU labeling experimentsrapidly lost.
The determination of the half-lives of the Ig cells is predicts a rapid loss of both types of cells in the absence
of B cell influx from the bone marrow. We tested thiscomplicated by the presence of immature B cells in the
Ig fraction. As these are short-lived cells (Allman et al., prediction by measuring the decay of Ig and Ig B cells
in IgTmf/TmCD21-cre animals over time, upon blocking1993), they may partly disappear from the system before
converting to Ig cells. The ratio of Ig:Ig cells in the B cell generation in the BM by chronic application of a
monoclonal anti-IL7-receptor antibody (Sudo et al.,blood of IgTmf/TmCD21-cre mice was close to 3:2 and
higher than that in the B1-8f/JHT CD21-cre system (data 1993).
Flow-cytometric analysis of B cell development in thenot shown). Assuming equal proportions of (convertible)
Ig and Ig cells in the steady state, the calculated half- BM of the treated animals indeed revealed a total block
of B cell generation (data not shown). Ig splenic B cellslives were 4.8 days for the Ig and 4.0 days for the Ig
cells in the blood of IgTmf/TmCD21-cre mice (Figure 5A, rapidly decayed, with a half-life of about six days (Figure
5D). This contrasts with the very slow decay of B cellsSupplemental Table S3 available on Cell website; for
calculations see Experimental Procedures). Using a in control animals under the same conditions (Sudo et
Cell
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Figure 6. Mature Resting B Cell Survival Depends on BCR Signaling
(A) B cell development in IgTmf/TmCD21-cre and B1-8f/JHT CD21-cre mice. Ig B cells are generated in the BM, mature in the spleen and
subsequently enter the Ig pool due to Cre-mediated mutagenesis. B cells persist in the Ig pool with a half-life of 3–6 days before they
undergo apoptosis.
(B) Resting mature B cells require signaling via the Ig/ heterodimer.
al., 1993; Hao and Rajewsky, 2001) and indicates a rapid involved transient B cell activation, thus being clearly
in need of further, direct experimental support. The workconversion of Ig into Ig B cells in the mutants. Accord-
of Lam et al. (1997) had shown that IFN-induced ablationingly, the fraction of Ig B cells increased upon blockade
of the IgH chain leads to the loss of mature B cellsof B cell generation in the bone marrow and became
within a period of 1–2 weeks. The partial rescue of thisdominant over time (Figures 5C and 5D). However, the
phenotype by a bcl-2 transgene indicated that the disap-Ig cells eventually also disappeared. We calculated the
pearance of the cells was due to apoptosis. From thispredicted decline of Ig and Ig cells, starting from their
evidence a “maintenance” signal was postulated for ma-abundance in the steady state. Critical for this calcula-
ture, resting B cells, which would be transmitted by thetion is the proportion of Ig cells that will convert to Ig
BCR either constitutively or upon low-affinity interactionones upon Cre-mediated recombination. Based on the
with some self antigen(s).evidence that 30% of the T1 and T2 cells make it into
Two main elements of this hypothesis required experi-the compartment of mature B cells (Allman et al., 1993),
mental support. The first is the postulated signal trans-the proportion of Ig, convertible cells was determined
mitted through the BCR. Is this a physiological signalto 4.0 of the 6.4 million B cells present in the spleen of
emanating from the signal-transducing unit of the BCR,the animals, leading to a ratio of (convertible) Ig/Ig
the Ig/Ig heterodimer, known to control B cell devel-cells of 1.3 at steady state. Using this ratio, decay curves
opment and the triggering of the cells into antibodywere calculated for the two cell types, assuming differ-
responses, or rather some ill-defined, perhaps arti-ent half-lives for the Ig cells (see Experimental Proce-
factual signal resulting from the disturbance of the gen-dures). As depicted in Figure 5D, the decay curves fitted
eral physiology of the cell by ablating a major receptorthe experimental data satisfactorily for a half-life of the
structure on its surface?Ig cells of 4.5 days, while half-lives of 3.5 or 5.5 days
The second issue that was left unresolved by the Lamwere incompatible with the data (Supplemental Figure
et al. (1997) experiment relates to a general problem ofS4 available on Cell website). If a higher proportion of
systems of inducible gene targeting, namely potentialIg cells was assumed to convert to Igcells, the half-life
side effects of the inducer beyond the desired inducedof the latter increased to up to six days (data not shown).
targeted mutagenesis. This problem is a priori difficultGiven that Cre-mediated recombination in the CD21-
to control, considering the possibility that such sidecre transgenic mice takes place mainly in mature B cells
effects may only become apparent in conjunction withas shown in the previous section, we conclude that loss
the induced mutation. In the Lam et al. (1997) experi-of the BCR at this developmental stage under conditions
ment, the problem is more obvious in that the inducer,in which there is no cellular activation, leads to a rapid
IFN, is a potent B cell activator. While this activation isloss of the mutant cells from the peripheral immune
transient and does not drive B cells into proliferationsystem, with an estimated half-life of 3–6 days. This
(Braun et al., 2002), it clearly goes hand-in-hand withis apparently also true for cells having undergone tail
the induction of targeted mutagenesis, raising the possi-mutation rather than ablation of Ig.
bility that the apoptosis seen upon BCR ablation may
happen in, and be characteristic of, activated or recently
Discussion activated rather than resting, mature B cells.
The present experiments address and resolve these
While the notion that the maintenance of mature, resting issues. They are based on the generation of the CD21-
B cells requires “tonic” signaling from the BCR (Lam et cre mouse strain in which Cre recombinase is expressed
al., 1997) has almost become a dogma in the field, it in the B cell lineage from the transition of immature to
seems to have been forgotten that it represented an mature B cells, and of conditional Ig alleles which either
interpretation of experimental evidence which ad- allow the ablation of Ig or the mutation of its signal-
transducing cytoplasmic tail. The latter mutation doesdressed BCR signaling only indirectly and in addition
Resting B Cell Survival Depends on BCR Signaling
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not eliminate the cytoplasmic tail altogether, but obliter- life ranges from 3–6 days, with 4–4.5 days as the most
likely average.ates a major portion of it, including the Ig ITAM motif
The fate of B cells having acquired the Ig tail mutation(see Supplemental Figure S1 available on Cell website).
was more difficult to analyze, since these cells could notIt is known from earlier work (Flaswinkel and Reth, 1994;
be easily distinguished from wild-type cells. However,Kraus et al., 1999; Torres et al., 1996), and we show again
based on the reduction of B cell numbers, Southern blothere (Supplemental Figure S3B and accompanying text
analysis, and comparison with the data obtained uponavailable on Cell website), that this kind of mutation
IFN-induced Ig tail mutation, it became clear that likedoes not preclude BCR expression. Indeed, the moder-
Ig ablation, interference with Ig signaling leads to theate downregulation of sIg seen upon Ig tail mutation
loss of mature B cells. A flow-cytometric analysis of thewas insufficient to allow the identification of the mutant
B cells in the mutant animals did not reveal any signscells by flow cytometry. However, in agreement with
of cellular activation and suggested that the mutant cellsprevious data (Pelanda et al., 2002; Minegishi et al.,
assume a surface phenotype resembling that of mature1999; Torres et al., 1996; Wang et al., 2002), both the
B cells having undergone BCR ablation. This argues thattail mutation and the complete ablation of Ig in the
the loss of the mature cells upon Ig mutation is due togerm line led to a severe block of B cell development
deficient rather than exaggerated BCR signaling as it iswhich was complete in the case of Ig ablation (Supple-
seen upon Ig truncation in immature BM B cells inmental Figure S3 available on Cell website).
certain situations (Kraus et al., 1999; Torres and Ha-In a first approach, we corroborated the previous IgH
fen, 1999).deletion experiment, ablating the BCR through IFN-
The model emerging from our results (Figure 6B)induced Ig inactivation. We observed that Ig ablation
states that the survival of mature, resting follicular, andindeed precluded the expression of BCRs of both the
MZ B cells in the peripheral immune system dependsIgM and IgD class and concluded from our results that
on BCR signaling through the Ig/Ig heterodimer.BCR ablation leads to the loss of mature B cells irrespec-
Given that the Ig cells in the mutant mice appear as ative of whether they have developed as a monoclonal
well-defined population when analyzed for sIg expres-or polyclonal population. Using the same experimental
sion by flow cytometry, one might conclude that in theprotocol we demonstrated a similar loss of B cells upon
absence of BCR-mediated survival signals mature BIg tail mutation. In both situations mature B cells of
cells have a half-life of 3–6 days, as determined in ourboth the follicular and MZ subsets were lost. This estab-
experiments. However, this half-life may also reflect thelished the existence of a maintenance signal transmitted
average time during which the cells loose residual BCRthrough the Ig/Ig heterodimer in these cells, but left
complexes whose turnover is slower than that of thethe issue of B cell activation by IFN unresolved.
bulk of the BCR expressed on the cell surface. In T cells,To address the latter point, we ablated IgH and Ig
there is evidence for such residual TCR complexesor mutated the Ig cytoplasmic tail in mature B cells
whose physiological relevance, however, remains to beusing the CD21-cre transgene for the induction of the
determined (Labrecque et al., 2001; Polic et al. 2001).mutations rather than IFN-induced Cre expression. De-
Whether the BCR-mediated survival signal is gener-velopmentally controlled transgene expression was ear-
ated upon BCR interaction with self antigens, akin tolier used by Meffre and Nussenzweig (2002) to demon-
the positive selection of T cells, or reflects constitutivestrate that Ig is required for the survival of immature
signaling by the BCR complex (Reth et al., 2000) cannotB cells in the BM. In the case of the CD21-cre transgene,
be decided at this stage. While there is evidence that B-1Cre-mediated recombination becomes detectable in
cells in the peritoneal and pleural cavities are positivelylate transitional and fully active in mature splenic B cells.
selected by self antigens (Hardy and Hayakawa, 2001),In the resulting steady state, mature B cells are gener-
evidence for such a selection is controversial for B-2ated as in wild-type mice, acquire the desired mutation
cells (Cariappa and Pillai, 2002; Gu et al., 1991; Levine
with only very limited mutagenesis at earlier develop-
et al., 2000), and there is no evidence that if it exists, it
mental stages, and subsequently lose BCR expression
is critical for the survival of the cells.
and/or BCR signaling (Figure 6A). In the case of BCR Apart from its unknown ultimate intracellular target,
ablation, Ig and Ig cells can be easily identified and it also remains to be established which downstream
separately analyzed. BrdU-labeling experiments dem- elements are involved in the transmission of the survival
onstrated that the Ig mature cells have a short half-life signal from the BCR. One possibility is the classical
in this system as expected, due to their conversion into pathway of NF-
B signaling, which is able to protect
Ig cells. The labeling data indicate a short half-life for cells from apoptosis (Karin and Lin, 2002), is set in mo-
the latter cells as well. These results accord with a reduc- tion upon BCR crosslinking (Ruland and Mak, 2003), and
tion of the total (Ig and Ig) B cell numbers in the is essential for mature B cell survival (Gerondakis and
peripheral immune system to about one third, in the Strasser, 2003; Pasparakis et al., 2002). The problem
absence of an accumulation of either type of cell over with this interpretation is that in bcl-10 and PKC knock-
time. By blocking B cell generation with an anti-IL7R out mice, in which BCR-mediated NF-
B activation is
antibody (Sudo et al., 1993), and subsequently counting abolished, mature B cells have been reported to be
Ig and Ig B cells in the periphery over time, we could generated in significant numbers (Leitges et al., 2001;
directly determine the half-lives of both types of cells. Ruland et al., 2001). However, a recent publication re-
Calculating cellular half-lives from the BrdU-labeling ports reduced numbers of follicular B cells in bcl-10
data on the one hand and the IL7R-blockade on the deficient mice (Xue et al., 2003), and the lifespan of these
other, we arrived at similar values for both the Ig→Ig cells has not been determined.
Most interestingly, a second signal required for ma-conversion and the half-life of Ig B cells. The latter half-
Cell
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manufacturer’s protocol (Miltenyi Biotec). For analysis of-gal activ-ture B cell survival has recently been identified. This
ity 5 106 cells were loaded with fluorescein di--D-galactopyrano-signal is transmitted through the BAFF receptor (BAFF-R),
side (Molecular Probes) as previously described (Nolan et al., 1988).a member of the tumor necrosis factor (TNF) receptor
Ig serum concentrations were determined by ELISA (Kraus et al.,
family, and is generated by interaction of this receptor 2001).
with the TNF-related BAFF ligand. BAFF is expressed
on a variety of cells of myeloid and other origin (Gorelik Induction of Cre Expression in Mx-cre Transgenic Mice
et al., 2003), and its pattern of expression might define Cre expression was induced by i.p. injection of p(I)/p(C) (400 g
in 400 l PBS; Pharmacia). Mice were given, depending on thethe compartmentalization of B cells in the peripheral
experiment, one injection every third day (e.g., on days 0, 3, and 6).immune system, such as the localization of B cell folli-
cles. Like BCR signaling, BAFF signaling activates
BrdU Labeling and Block of B Cell GenerationNF-
B most prominently (but not exclusively) through
Mice were given BrdU in the drinking water (0.8 mg/ml; Sigma)the so-called alternative pathway of NF-
B signaling
for 14 days. Lymphocytes were stained for B220 and sIgM. BrdU
(Kayagaki et al., 2002; Hatada et al., 2003). The interplay incorporation was determined using the BrdU Flow Kit (BD Biosci-
between survival signals from the BCR on the one hand ences). B cell generation in the BM was blocked by i.v. injections
and the BAFF-R on the other will be interesting to study. of 1 mg anti-IL7R MAb (A7R34) every second day.
Smith and Cancro (2003) suggest that BAFF-R expres-
sion can be enhanced by signals from the BCR. Perhaps, Calculating the Half-Life of Ig Cells
We model the decay of the number np of Ig cells as:the two survival signals converge in the cell downstream
of the classical and alternative pathway of NF-
B sig-
np(t) (t  dt) 	 np(t)   * dt * np(t)   * dt * np(t) (1)
naling.
Physiologically, it seems reasonable to have B cell  is the death rate of Ig cells and  is the conversion rate from Ig
to Ig cells. In particular, the number Ig cells is independent of themaintenance depend on separate survival signals, con-
number of Ig cells. The number nm of Ig cells is then:trolling the B cell habitat (BAFF-BAFF-R) and monitoring
B cell function with respect to a functionally competent nm(t  dt) 	 nm(t)   * dt * nm(t)   * dt * np(t) (2)
BCR. In contrast to T cells, whose dependence on TCR
We want to calculate , the true half-life time of Ig cells. Note thatexpression is less stringent (Labrecque et al., 2001; Polic
nm(t) depends on np(t). Straightforward solution of the coupledet al. 2001), B cells are subject to somatic hypermutation
differential equations (1) and (2) gives:and therefore at a higher risk of losing antigen receptor
expression through the acquisition of inappropriate so- np(t) 	 np(t 	 0) * exp(-(  )*t) and (3)
matic mutations. The dependence of B cells on BCR
(a) nm(t) 	 A*exp(-(  )*t)  B*exp(-*t) (4)signaling makes the signaling cascade activated through
the BCR an attractive candidate for therapeutic interven- with A 	 ( *np(t 	 0))/(-- ), B 	 nm(t 	 0)
tion in B cell dependent diseases. It will be interesting
 ( *np(t 	 0))/(-- ) for     
to explore to which extent B cell lymphomas retain the
(b) nm(t) 	 [nm(t 	 0)  np(t 	 0) *  * t] * exp(-*t) for  	   BCR dependence of their B cell progenitors.
We can measure the time T in which nm(t 	 0) decays to
Experimental Procedures 0.5*nm(t 	 0).
Corresponding to 4 (a), (b) we obtain two transcendental equa-
Mice tions:
The generation of IgTmf, IgClf and CD21-cre mice is described in
the Supplemental Material (available on Cell website). Other mouse (a)  	     2** *exp(-( )*T) 
strains used in this study: C57BL/6 (Jackson Laboratory), Mx-cre
2*(--* (1 ))*exp(-*T) (5)(Ku¨hn et al., 1995), deleter (Schwenk et al., 1995), Igc/c (Torres et
al., 1996), B1-8f (Lam et al., 1997), JHT (Gu et al., 1993), and ROSA26-
(b) 0.5*exp((  )*T) 	 1   *  * T (case  	   )flSTOP-geo (Mao et al., 1999). Mice were analyzed at the age of
6–16 weeks. IgTm/Tm mice were on C57BL/6 genetic background with  	 np(t 	 0)/nm(t 	 0). (6)
while other experimental mice were of mixed 129 and C57BL/6 back-
ground.  was set to log(2)/(44.7 days) for the BrdU labeling experiments,
and to log(2)/134 days for the anti-IL7R blocking experiment (Hao
and Rajewsky, 2001). 5a was solved numerically by screening Flow Cytometry
values within a precision of 1e-6. Since we do not know the exactLymphoid cells were prepared and stained as described previously
ratio of Ig/Ig,  was multiplied with a factor ranging from 1/3 to 3.(Kraus et al., 2001). Stained cells were acquired on a FACSCalibur
(BD Biosciences) and data analyzed using CELLQuest software (BD
Biosciences). Dead cells were labeled with propidium iodide or TO- Acknowledgments
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